These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9274428)

  • 1. The usefulness of screening data for studying the biology of breast cancer.
    van Dongen JA
    Eur J Cancer; 1997 Apr; 33(4):519-20. PubMed ID: 9274428
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for breast cancer detects tumours at an earlier biological stage.
    Abernathy CM; Hedegaard H; Weger N
    Br J Surg; 1994 Jun; 81(6):922. PubMed ID: 8044626
    [No Abstract]   [Full Text] [Related]  

  • 3. Wounding from biopsy and breast-cancer progression.
    Retsky M; Demicheli R; Hrushesky W
    Lancet; 2001 Mar; 357(9261):1048. PubMed ID: 11293631
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening mammography reduces morbidity of breast cancer treatment.
    Leung JW
    AJR Am J Roentgenol; 2005 May; 184(5):1508-9. PubMed ID: 15855106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal breast cancer: a clinically meaningful term?
    Saccani Jotti G; Petit JY; Contesso G
    Semin Oncol; 1986 Dec; 13(4):384-92. PubMed ID: 3541210
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of early detection of breast cancer by mass screening in Miyagi Prefecture].
    Abe R; Sato T; Yoshida K; Hariu T; Takahashi K; Kanno H; Matoba N
    Nihon Geka Gakkai Zasshi; 1985 Aug; 86(8):941-7. PubMed ID: 4058414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An evaluation of the clinical course and prognosis of breast cancers detected by mass screening].
    Imamura F; Tamura K; Uchino J; Hata Y; Nakanishi M; Uemura T; Ogita M; Sasaki M; Nakashima S; Narimatsu H
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2298-304. PubMed ID: 3831174
    [No Abstract]   [Full Text] [Related]  

  • 8. [A comparative analysis of interval breast cancer with breast cancer detected by mass screening or in outpatient clinics].
    Komaki K; Morimoto T; Oshimo K; Mori T; Sasa M; Konishi Y; Monden Y
    Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):413-8. PubMed ID: 1603047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined clinical and mammographic mass screening in breast cancer].
    Lányi M; László G; Farkas M
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Jan; 11(1):18-26. PubMed ID: 4324683
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative pathology of prevalent and incident cancers detected by breast screening. Edinburgh Breast Screening Project.
    Anderson TJ; Lamb J; Alexander F; Lutz W; Chetty U; Forrest AP; Kirkpatrick A; Muir B; Roberts MM; Huggins A
    Lancet; 1986 Mar; 1(8480):519-23. PubMed ID: 2869259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Paci E; Ponti A; Crocetti E; Zappa M; Segnan N
    J Natl Cancer Inst; 2005 Dec; 97(24):1853-4; author reply 1854. PubMed ID: 16368949
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective screening for breast cancer in Guildford.
    Thomas BA
    Lancet; 1975 Nov; 2(7941):914-5. PubMed ID: 53384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast screening in Geneva?].
    Schaefer P
    Helv Chir Acta; 1992 May; 59(1):195-202. PubMed ID: 1526828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The care of the patient with minimal breast cancer.
    Letton AH; Wilson JP; Mason EM
    Am Surg; 1978 Sep; 44(9):541-7. PubMed ID: 717903
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing the effect of hormone replacement therapy on the performance of screening mammography.
    Thomas CM
    Radiology; 1999 Dec; 213(3):926-7. PubMed ID: 10580977
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Tumor characteristics and clinical outcome of elderly women with breast cancer.
    Basche M; Byers T
    J Natl Cancer Inst; 2001 Jan; 93(1):64-5; author reply 65-6. PubMed ID: 11136846
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer screening in high-risk women. Rotterdam Committee of Medical and Genetic Counseling.
    Brekelmans CT; Bartels CC; Crepin E; van Geel AN; Meijers-Heijboer H; Seynaeve C; Tilanus-Linthorst MM; Verhoog LC; Wagner A; Klijn JG
    Dis Markers; 1999 Oct; 15(1-3):34-6. PubMed ID: 10595248
    [No Abstract]   [Full Text] [Related]  

  • 18. Do non-specific minimal signs in a biennial mammographic breast cancer screening programme need further diagnostic assessment?
    Maes RM; Dronkers DJ; Hendriks JH; Thijssen MA; Nab HW
    Br J Radiol; 1997 Jan; 70():34-38. PubMed ID: 9059292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass screening for breast cancer: current concepts.
    Schwartz GF; Shaber GS; Feig SA; Patchefsky AS; Nerlinger RE; Franco J; Wallace JD
    Am J Obstet Gynecol; 1978 Feb; 130(3):359-60. PubMed ID: 623174
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic factors of breast neoplasms detected on screening by mammography and physical examination.
    Feig SA; Schwartz GF; Nerlinger R; Edeiken J
    Radiology; 1979 Dec; 133(3 Pt 1):577-82. PubMed ID: 504635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.